Daily Chart

Dendreon Corp (DNDN) Financial News - Soros Fund Management Holdings in 2nd Quarter: 13F Alert

Dendreon Corp (DNDN)

Soros Fund Management Holdings in 2nd Quarter: 13F Alert

2011-08-16 03:45:46
Quote: Top Positions by Market ValueCompany NameTickerMarket ValueCurrentChange(USD $)PositionIn Position Adecoagro SAAGRO US295,147,82826,446,938-711,755 Motorola Solutions IncMSI US260,684,8805,662,1391,181,529 Interoil CorpIOC US232,262,5833,969,622-77,700 Polo Ralph Lauren CorpRL US131,895,497994,612498,244 Westport Innovations IncWPRT US120,577,7585,019,890-527,714 Visteon CorpVC US108,809,1831,590,545-543,561 Dendreon CorpDNDN US102,006,2752,586,366-2,085,333 Emdeon Inc-Class AEM US90,707,9806,913,718-238,300 Danaher CorpDHR US83,802,9431,581,486-290,284 Thermo Fisher Scientific Inc TMO US60,339,869937,100482,100Top New Buys by Market ValueCompany NameTickerMarket ValueCurrentChange(USD $)PositionIn Position Golar Lng Partners LPGMLP US35,055,0001,230,0001,230,000 Intl Business Machines CorpIBM US25,801,120150,400150,400 Semiconductor HOLDRS TrustSMH US19,688,016577,700577,700 VMware Inc-Class AVMW US15,034,500150,000150,000 SandRidge Energy IncSD US14,924,0001,400,0001,400,000Top Sell Outs by Market ValueCompany NameTickerMV ChangeCurrentChange(USD $)PositionIn Position Google Inc-Cl AGOOG US-68,186,2060-116,208 Coach IncCOH US-45,573,3530-875,737 NovaGold Resources IncNG US-45,397,3000-3,492,100 Power-One IncPWER US-24,810,1880-2,835,450 Tenet Healthcare CorpTHC US-24,585,0000-3,300,000Top Position Increases by Market ValueCompany NameTickerMV ChangeCurrentChange(USD $)PositionIn Position Polo Ralph Lauren CorpRL US70,519,594994,612498,244 Motorola Solutions IncMSI US60,446,4195,662,1391,181,529 Time Warner CableTWC US53,125,673743,031674,900 Seagate TechnologySTX US49,074,3353,523,8002,977,443 Thermo Fisher Scientific Inc TMO US35,064,619937,100482,100Top Position Decreases By Market ValueCompany NameTickerMV ChangeCurrentChange(USD $)PositionIn Position Monsanto CoMON US-186,379,51979,400-2,579,598 Citigroup IncC US-127,191,88964,600-2,873,903 Wells Fargo & CoWFC US-108,966,45977,700-3,427,400 Teva Pharmaceutical-Sp ADRTEVA US-105,066,47241,400-2,0...
Open whole article (external link)

Other Financial and Stock Market News concerning Dendreon Corp

Take a Chance on Dendreon Corp (2011-08-17 06:16:57)
10 Stocks Billionaire Steven Cohen Is Buying (2011-08-17 06:16:57)
Faruqi & Faruqi, LLP Announces Investigation of Dendreon Corp. (2011-08-17 06:16:56)
Dendreon: Profits Ahead as Provenge Gets Reimbursement Approval From Medicare (2011-08-17 06:16:56)
Tuesday Options Recap (2011-08-17 06:16:53)
A Few More Health Care Companies Beat Down With the Market (2011-08-16 03:45:48)
Dendreon and Provenge: Too High of a Risk for the Reward (2011-08-16 03:45:47)
It's Buy Time in the Health Sector With the Market Tanking (2011-08-16 03:45:47)
Soros Fund Management Holdings in 2nd Quarter: 13F Alert (2011-08-16 03:45:46)
Hagens Berman Reminds Investors of Deadline in Securities Class-Action Lawsuit against Dendreon (2011-08-15 09:03:06)
5 Cheap Biotech Stocks That May Rebound Ahead of the Market (2011-08-12 10:28:58)
Apricus Biosciences: A Victim of Market Hysteria (2011-08-11 04:51:19)
Big Pharma Boosts Dependence on Dendreon and Zalicus (2011-08-10 07:34:11)
Which Seattle-area stocks are down the most? (2011-08-09 01:44:59)
Top Buy and Sell Ideas From Last Week's Big Biotech Movers (2011-08-09 01:44:58)
How to Find Opportunities After a Flood of 20% Decliners Last Week: Part 1 (2011-08-08 11:53:46)
How Dendreon Can Fix Its Broken Relationship With Wall Street (2011-08-05 08:22:18)
Kahn Swick & Foti, LLC and Former Louisiana Attorney General Announce Suit Against Dendreon Corp.: Remind Investors With Large Financial Interests of Important 10/3/11 Deadline - DNDN (2011-08-05 08:22:17)
[$$] Dendreon Shares Plunge on Uncertainty About Cancer Drug (2011-08-05 08:22:17)
A Look at Thursday's 5 Biggest Losers (2011-08-05 08:22:16)
Biotech Stock Mailbag: Dendreon's Aftermath (2011-08-05 08:22:16)
Buying Dendreon on Thursday's Plunge (2011-08-05 08:22:15)
Dendreon Earnings: Provenge Whiffs Badly (2011-08-04 04:55:33)
Dendreon Scraps Sales Forecast on Slow Prostate Drug Sales; Shares Plunge (2011-08-04 04:55:32)
UPDATE 3-Dendreon pulls forecast as Provenge falls short (2011-08-04 04:55:32)
[$$] Setback for Dendreon Cancer Drug (2011-08-04 04:55:30)
Dendreon skids after nixing Provenge sales target (2011-08-04 04:55:30)
Dendreon, Zipcar: After-Hours Trading (2011-08-04 04:55:30)
Dendreon Corp's CEO Discusses Q2 2011 Results - Earnings Call Transcript (2011-08-04 04:55:29)
Avis, Dendreon, Entropic, Sotheby’s, Zipcar: U.S. Equity Preview (2011-08-04 04:55:28)
Q2 2011 Dendreon Corp Earnings Release - Time Not Supplied (2011-08-03 09:07:59)
Dendreon Earnings Preview: It's All About Provenge Sales (2011-08-02 05:51:11)
4 Falling Healthcare Stocks to Consider (2011-08-02 05:51:10)
August Catalysts for Biotech and Drug Stocks (2011-08-01 12:06:07)
Abolish the FDA; it's insane (2011-07-28 04:03:15)
Short, Long Term Catalysts Keep Immunocellular on the Radar (2011-07-27 05:56:15)
6 more reasons bubble talk is insane (2011-07-19 06:50:49)
Covered Calls: Mandatory Option Trading Techniques for the Income Investor (2011-07-19 06:50:48)
Uplisting May Be Next For ImmunoCellular Therapeutics (2011-07-18 02:04:44)
Top Biotech Picks of High Alpha Funds (2011-07-15 06:25:10)
7 Companies Expected to Grow Earnings Rapidly Next Year (2011-07-13 08:21:00)
Dendreon and ADVENTRX Present Promising Pipelines (2011-07-12 09:20:26)
Ideas in the Biotech Sector (2011-07-11 02:30:15)
Dendreon to Host Conference Call on August 3, 2011 to Announce Second Quarter 2011 Financial Results (2011-07-11 02:30:15)
Dendreon News Could Limit Long Term Upside (2011-07-11 02:30:14)
Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE (2011-07-06 11:17:51)
InPlay: Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of Provenge (2011-07-06 11:17:50)
DENDREON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (2011-07-04 08:37:26)
Stocks Log Best Week in Almost Two Years (2011-07-04 08:37:24)
Dendreon Receives Good News on Reimbursement for Provenge (2011-07-04 08:37:24)

Dendreon Corp Stock Summary

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. The company?s product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers. The company offers PROVENGE (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic, metastatic, castrate-resistant (hormone-refractory), and prostate cancer. Its product candidates under development comprise DN24-02, an investigational cellular immunotherapy targeted towards HER2/neu for the treatment of patients with bladder, breast, ovarian, and other solid tumors; carbonic anhydrase 9, an antigen expressed in renal cell carcinoma; carcinoembryonic antigen, an antigen expressed in colorectal and other cancers; and TRPM8, a small molecule to treat multiple cancers in advanced cancer patients. Dendreon Corporation was founded in 1992 and is headquartered in Seattle, Washington.
Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.

This website is a service of the HagensMedia ad network. For advertising please visit http://www.hagensmedia.com - Copyright 2011-2012.